Trail activity in human ovarian cancer cells: potentiation of the action of cytotoxic drugs (Q40762117)

23 September 2017

Trail activity in human ovarian cancer cells: potentiation of the action of cytotoxic drugs (English)

1 reference

23 September 2017

0 references

1 reference

Vignati S

1

1 reference

23 September 2017

Codegoni A

series ordinal

2

1 reference

23 September 2017

Polato F

series ordinal

3

1 reference

23 September 2017

Broggini M

series ordinal

4

1 reference

23 September 2017

1 January 2002

1 reference

European Journal of Cancer

23 September 2017

1 reference

23 September 2017

38

1 reference

23 September 2017

1

1 reference

23 September 2017

177-183

1 reference

DDP-induced cytotoxicity is not influenced by p53 in nine human ovarian cancer cell lines with different p53 status.

23 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900345-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900345-8

1 reference

7 January 2021

Driving p53 response to Bax activation greatly enhances sensitivity to taxol by inducing massive apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900345-8

7 January 2021

PIK3CA is implicated as an oncogene in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900345-8

7 January 2021

The 1995 Walter Hubert Lecture--molecular epidemiology of human cancer: insights from the mutational analysis of the p53 tumour-suppressor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900345-8

7 January 2021

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900345-8

7 January 2021

Resistance to TRAIL-induced apoptosis in primitive neuroectodermal brain tumor cells correlates with a loss of caspase-8 expression.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900345-8

7 January 2021

p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900345-8

7 January 2021

On the TRAIL from p53 to apoptosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900345-8

7 January 2021

TRAIL-induced apoptosis of thyroid cancer cells: potential for therapeutic intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900345-8

7 January 2021

Autoamplification of apoptosis following ligation of CD95-L, TRAIL and TNF-α

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900345-8

7 January 2021

The TRAIL to selective tumor death

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900345-8

7 January 2021

Inhibition of death receptor signals by cellular FLIP

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900345-8

7 January 2021

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900345-8

7 January 2021

Increased expression of death receptors 4 and 5 synergizes the apoptosis response to combined treatment with etoposide and TRAIL

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900345-8

7 January 2021

Epithelial ovarian cancer: prevention, diagnosis, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900345-8

7 January 2021

The antiapoptotic decoy receptor TRID/TRAIL-R3 is a p53-regulated DNA damage-inducible gene that is overexpressed in primary tumors of the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900345-8

7 January 2021

10.1016/S0959-8049(01)00345-8

Identifiers

DOI

1 reference

23 September 2017

1 reference